rifapentine

SynDRA canonical compound SYN0041769 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP2C8 \| CYP2C9 \| CYP3A4
Mechanism of action	RNA polymerase inhibitor
Indication	tuberculosis
Disease area	infectious disease

All known targets

CYP2C8
CYP2C9
CYP3A4
rpoA
rpoB
rpoC
rpoZ

Mechanisms of action (all sources)

RNA polymerase inhibitor
rpoA INHIBITOR
rpoZ INHIBITOR
rpoC INHIBITOR
rpoB INHIBITOR

Drug classes

Rifamycin Antimycobacterial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antitubercular Agents
Leprostatic Agents

ATC classes

DRUGS FOR TREATMENT OF TUBERCULOSIS

Cross-references

PubChem CID: 135403821
ChEMBL: CHEMBL1660
DrugBank: DB01201
ChEBI: CHEBI:45304
KEGG: D00879

Synonyms

DL473
3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV
RISDZDVHYCURHD-QLWTZYDESA-N
HMS3259L06
NC00700
NS00011699
R0198
Antibiotic DL 473IT

Look up rifapentine in the interactive SynDRA portal →